Table 7. Convergent validity results.
PEST | ||
r | *p | |
CASPAR | 0.455 | <0.001 |
ToPAS 2 | 0.763 | <0.001 |
PEST: Psoriasis Epidemiology Screening Tool; CASPAR: Classification Criteria for Psoriatic Arthritis; ToPAS 2: Toronto Psoriatic Arthritis Screen 2; r: Spearman’s rho coefficient; * p<0.05, statistically significant. |